TheProfitWatch

APLS - Apellis Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
19.35 0.26 (1.34%) -0.01 (-0.05%) -0.01 (-0.05%) -0.28 (-1.41%) 0.32 (1.65%) 0.16 (0.82%) --- 0.32 (1.65%)

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.33
Diluted EPS:
-0.33
Basic P/E:
-59.4242
Diluted P/E:
-59.4242
RSI(14) 1m:
46.43
VWAP:
19.61
RVol:

Events

Period Kind Movement Occurred At

Related News